Top Premarket Decliners

MT Newswires Live
Jan 02

Outlook Therapeutics (OTLK) shares were down 61% in recent Friday premarket activity, after the company said Wednesday the US Food and Drug Administration has issued a complete response letter to the ONS-5010 biologics license application resubmission.

Intelligent Bio Solutions (INBS) stock was down 19%, partly erasing Wednesday's surge.

Nuvve (NVVE) shares were more than 8% lower after the company said Wednesday it closed a private placement of Series A convertible preferred stock and related warrants, raising gross proceeds of $5.4 million.

Kandal M Venture (FMFC) shares were down 7.1% after the leather goods producer said Wednesday its Chief Executive Ngee Woon Lim resigned and will step down on June 30.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10